Janelle N Van Arsdell

Title: Janelle N Van Arsdell: Innovator in Immunology

Introduction

Janelle N Van Arsdell is a prominent inventor based in Oakland, CA (US). She has made significant contributions to the field of immunology, particularly through her innovative work on colony stimulating factors.

Latest Patents

Janelle holds a total of 7 patents, with her latest inventions focusing on DNA encoding for colony stimulating factors. One of her notable patents is for the DNA encoding N∇2 CSF-1 and its carboxy truncated fragment. This lymphokine is essential for regulating the immune system and can help overcome immunosuppression caused by chemotherapy or other factors. The CSF-1 protein is produced using recombinant methods, including the cloning and expression of murine and human DNA sequences. Both "long" and "short" forms of this protein, along with muteins corresponding to the cDNA-encoded forms, are disclosed in her patent. Another significant patent involves DNA encoding NV2 and its carboxy truncated fragments, which also pertains to the CSF-1 protein and its applications in immune regulation.

Career Highlights

Throughout her career, Janelle has worked with notable companies such as Cetus Corporation and Chiron Corporation. Her work has been instrumental in advancing the understanding and application of colony stimulating factors in medical science.

Collaborations

Janelle has collaborated with esteemed colleagues, including Martha B Ladner and Alice M Wang, contributing to her innovative research and development in the field.

Conclusion

Janelle N Van Arsdell's contributions to immunology through her patents and collaborations highlight her role as a leading inventor in the field. Her work continues to impact the medical community and improve therapeutic approaches for patients.